PAR 0.00% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Receives $7.36m R&D Tax Incentive Refund, page-19

  1. 7,552 Posts.
    lightbulb Created with Sketch. 6830
    Yeah, apologies, I think we are at crossed wires in saying the same thing, i.e. the January expenditure indicated by today's report not quite as surprising some seem to think above.

    The $6M indicated January spend from the reported balance in fact in keeping or even perhaps less (given higher initial outlay expenses reported) than the $8 - $11M (including R&D refund) qtrly spend guidance (i.e. $15.5 - 18.5M spend guidance excluding refund).

    Perhaps explaining the (relief?) rally today - PAR having blown out on previous guidance.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.